Abuse, Drug
9
3
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Cannabis Effects as a Function of Sex
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
Age-dependent Effects of Smoked and Oral Delta-9-THC
Analgesic and Subjective Effects of Terpenes
A Study to Assess the Abuse Potential of Intranasal Cebranopadol
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users